Nowadays, the diagnosis of PCa is based on a histopathological examination of the biopsy specimen, and prognosis and treatment depend on the biopsy Gleason sum and serum concentration of prostate-specific antigen (PSA) [5]. This evidence concerns the gene KLK3 and posterior cortical atrophy.